Omada Health, Inc.
NASDAQOMDA heads into its May 11 Q1 report having rallied 30% in a month — a sprint that leaves analysts broadly supportive but scrambling to justify the price. The clearest tension in the setup is between a stock that has already moved hard and a borrow market that shows no sign of stress. Short interest is a modest 6.2% of the free float — real, but not aggressive — and it has eased…
Snapshot as of 23 Jun 2026
OMDA heads into its May 11 Q1 report having rallied 30% in a month — a sprint that leaves analysts broadly supportive but scrambling to justify the price. The clearest tension in the setup is between a stock that has…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for OMDA — free to start on ORTEX.
Sign up for free →Open OMDA on ORTEX